<http://schema.org/description>
"Fourth-quarter results released by Amgen were roughly in line with Wall Street estimates. So, while shares didn&amp;#039;t react particularly strongly (and have pretty much tracked the wider Nasdaq"^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.aol.com/article/2014/02/09/why-you-shouldnt-overlook-amgen-inc/20826493/?gen=1>